News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in ...
A new approach by chemists could help to significantly improve diagnostic tests based on PCR. The enzymes used are triggered by light pulses. DNA polymerases and other enzymes that modify DNA are ...
Designing reproducible PCR assays involves optimizing multiple moving targets, from standardizing each component in sometimes minute reaction volumes to planning ahead to ensure long-term and secure ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results